FDA approves muscle-targeted SMA therapy

• by Kathryn Wighton

• September 14, 2026

“Do It by Myself” or Autonomy, Participation, and Assistive Devices and Technology Needs of Children and Youth With Disabilities: Text Mining Analysis of a National Survey in France

• by Johanne Mensah Gourmel, Maxime Bourgain, Maxime Galloy, Mario Veruete, Gwenaël Cornec, Sylvain Brochard, Christelle Pons, Arriel Benis

• July 8, 2026

Volatility priors may reveal delusion severity in schizophrenia

Expectations of environmental instability declined alongside delusional symptoms during 6 months following an acute psychotic episode.

• by Andrea Surnit

• August 25, 2026

• 4 min

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.

• by Kathryn Wighton

• September 4, 2026

• 2 min